The CoolLipo System.

The CoolLipo System delivers calibrated cooling to localised treatment zones, inducing apoptosis of subcutaneous adipocytes while sparing surrounding tissue. The body processes treated cells through standard metabolic pathways over the weeks following treatment.

The result is a measurable reduction in localised subcutaneous fat thickness, with the dermis, nerves, and surrounding structure preserved.

• AbdomenLocalised pinchable fat
• FlanksBilateral contour
• ThighsInner and outer zones
• BackBra-line and lower back
• ArmsUpper-arm bilateral
• Sub-mentalUnder-chin contour

Treatment is delivered by Elsa Medical Certified Providers following a clinical consultation. Patient-selection criteria apply.

Each CoolLipo cycle treats a defined zone with calibrated cooling delivered at controlled temperature and duration. Treatment areas may be addressed in a single session or staged across multiple sessions, per clinical plan.

Reduction develops progressively over the weeks following treatment, with final outcomes typically evident at three to four months. Additional cycles per area may be planned to optimise outcome.

• ModalityCryolipolysis
• DeliveryControlled cooling, calibrated temperature
• Tissue effectSelective adipocyte apoptosis
• Surface preservationDermis, nerves, surrounding tissue
• Session protocolPer area, repeatable
• Provider deliveryElsa Medical Certified Providers only

Every CoolLipo treatment is delivered by qualified clinical staff trained and certified on the platform. Certification covers technique, patient selection, safety, and ongoing audit — a single clinical standard, consistently applied.